Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TLV/EVGN stock hub

TLV/EVGN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TLV/EVGNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

24.9M

Tel Aviv Stock Exchange

Market data

Price

Recent price action with selectable time range.

TLV/EVGNTLV/EVGN

—

Loading chart…

In the news

Latest news · TLV/EVGN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-100.7

P25 n/aP50 n/aP75 n/a

ROIC-54.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TLV/EVGN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

180

Groups with data

Currency

USD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Israel
Country code	IL
Employees	52
Employees Change	-65%
Employees Change Percent	-55.56
Enterprise value	ILA 29M
Exchange	Tel Aviv Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	IL0011050551
Last refreshed	2026-05-10
Market cap	ILA 24.9M
Price	ILA 239
Price currency	ILA
Rev Per Employee	236,218.54x
Sector	Healthcare
Sic	2836
Symbol	tlv/EVGN
Website	https://www.evogene.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-108.6%
EV Earnings	-1.07x
EV/FCF	-0.67x
EV/Sales	2.36x
FCF yield	-174.55%
P/B ratio	0.65x
P/S ratio	2.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-6.25%
Gross Profit	ILA -768,308
Net Income	ILA -27.1M
Net Income Growth Years	4%
Pretax Margin	-350.32%
Profit Margin	-220.22%
Profit Per Employee	ILA -520,196
ROA	-28.77
Roa5y	-26.27
ROCE	-83.05
ROE	-100.7
Roe5y	-69.88
ROIC	-54.69

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-37.79%
Cagr15y	-28.14%
Cagr1y	-41.42%
Cagr3y	-51.91%
Cagr5y	-54.47%
EPS Growth Years	1
Revenue Growth	-30.91x
Revenue Growth Years	0x
Revenue Growth3 Y	32.01x
Revenue Growth5 Y	29.94x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ILA 0.13
Assets	ILA 63.9M
Cash	ILA 41.3M
Current Assets	ILA 45.3M
Current Liabilities	ILA 10M
Debt	ILA 7M
Debt Equity	ILA 0.18
Debt FCF	ILA -0.16
Equity	ILA 38.2M
Interest Coverage	-87.82
Liabilities	ILA 25.7M
Long Term Assets	ILA 18.6M
Long Term Liabilities	ILA 15.7M
Net Cash	ILA 34.3M
Net Cash By Market Cap	ILA 138
Net Cash Growth	-15.94%
Net Debt Equity	ILA -0.9
Tangible Book Value	ILA -261,416
Tangible Book Value Per Share	ILA -0.03
WACC	7.99

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.54
Inventory Turnover	4.04
Net Working Capital	ILA -168,964
Quick ratio	3.96
Working Capital	ILA 38.9M
Working Capital Turnover	ILA 1.63

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-38.21%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.13%
1Y total return	-41.4%
200-day SMA	351.9
3Y total return	-88.88%
50-day SMA	252.4
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.04%
All Time High	69,950
All Time High Change	-99.66%
All Time High Date	2014-01-01
All Time Low	221
All Time Low Change	8.24%
All Time Low Date	2026-05-05
ATR	11.22
Beta	0.8
Beta1y	0.16
Beta2y	0.33
Ch YTD	-20.43
High	241
High52	1,085
High52 Date	2025-06-10
High52ch	-77.95%
Low	233.1
Low52	221
Low52 Date	2026-05-05
Low52ch	8.24%
Ma50ch	-5.24%
Price vs 200-day SMA	-32.04%
RSI	45.59
RSI Monthly	32.15
RSI Weekly	21.05
Sharpe ratio	-0.37x
Sortino ratio	-0.69
Total Return	-38.21%
Tr YTD	-20.43
Tr15y	-99.3%
Tr1m	-7.39%
Tr1w	5.1%
Tr3m	-27.45%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ILA -44M
Operating margin	-357.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10,328,878%
Net Borrowing	-1,525,926
Shares Insiders	0.81%
Shares Institutions	2.02%
Shares Out	10,412,764
Shares Qo Q	0.02%
Shares Yo Y	38.21%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ILA -45.6M
Average Volume	22,707.3x
Bv Per Share	-0.03
CAPEX	ILA -430,380
Ch10y	-99.13
Ch15y	-99.3
Ch1m	-7.39
Ch1w	5.1
Ch1y	-41.4
Ch3m	-27.45
Ch3y	-88.88
Ch5y	-98.04
Ch6m	-38.7
Change	-0.25%
Change From Open	-0.25
Close	239.8
Days Gap	0
Depreciation Amortization	1,520,124
Dollar Volume	1,527,531.2
Earnings Date	2026-05-20
EBIT	ILA -44M
EBITDA	ILA -42.3M
EPS	ILA -3.44
F Score	2
FCF	ILA -43.5M
FCF EV Yield	-149.66x
FCF Per Share	ILA -4.18
Financing CF	-21,047,176
Fiscal Year End	December
Founded	1,999
Income Tax	ILA 3,188
Investing CF	56,548,744
Is Primary Listing	1
Last Earnings Date	2026-03-05
Last Report Date	2025-12-31
Last Split Date	2024-07-28
Last Split Type	Reverse
Ma150	326.4
Ma150ch	-26.71%
Ma20	240.3
Ma20ch	-0.45%
Net CF	-7,475,860
Next Earnings Date	2026-05-20
Open	239.8
Position In Range	77.22
Ppne	7,647,036
Price Date	2026-05-08
Relative Volume	0.28x
Revenue	12,283,364x
SBC By Revenue	16.97x
Share Based Comp	2,084,952
Tax By Revenue	0.03x
Tr6m	-38.7%
Volume	6,386
Z Score	-20.34

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TLV/EVGN pay a dividend?

Capital-return profile for this ticker.

Performance

TLV/EVGN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TLV/EVGN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.0%

Share of float held by funds and institutions

Insider ownership

+0.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+38.2%

Negative means the company is buying back shares.

Technical

TLV/EVGN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.6

Neutral momentum band

Price vs 200-day MA

-32.0%

50/200-day relationship not available

Beta (5Y)

0.80

Less volatile than the market

Sharpe ratio

-0.37

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TLV/EVGN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tlv/EVGN stock rating?

tlv/EVGN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tlv/EVGN analysis?

The full report lives at /stocks/tlv/EVGN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tlv/EVGN?

The latest report frames tlv/EVGN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tlv/EVGN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.